Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers
Open Access
- 16 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e49814
Abstract
The detection of incidental findings (IF) in magnetic resonance imaging (MRI) studies is common and increases as a function of age. Responsible handling of IF is required, with implications for the conduct of research and the provision of good clinical care. To investigate the prevalence and clinical significance of IF in a prospective cohort of healthy elderly volunteers who underwent MRI of the torso as a baseline investigation for a phase I trial. We assessed the follow-up pathway with consequent cost implications and impact on trial outcomes. A total of 29 elderly healthy volunteers (mean age 67, range 61–77, 59% female) were eligible at screening and underwent MRI for assessment of visceral and subcutaneous fat. IF were detected in 19 subjects (66%). Suspected IF of high and low clinical significance were found in 14% and 52% of participants, respectively. Follow up of IF was conducted in 18 individuals, confirming abnormalities in 13 subjects, 3 of whom were recommended for deferred clinical re-evaluation. The remaining 5 subjects had false positive IF based on second line imaging tests. Costs of follow-up medical care were considerable. MRI abnormalities are common in elderly individuals, as a result of age and non-diagnostic quality of research scans. In the presence of IF in the context of clinical trials, immediate referrals and follow up assessments may be required to rule out suspected pathology prior to exposing trial participants to investigational medicine products (IMP). Unanticipated costs, ethical implication and the possible impact of IF on trial outcomes need to be taken into account when designing and conducting trials with an IMP.Keywords
This publication has 32 references indexed in Scilit:
- Management of incidental findings during imaging research in “healthy” volunteers: current UK practiceBritish Journal of Radiology, 2012
- Understanding pharmacology in humans: Phase I and Phase II (Data Generation)Current Opinion in Pharmacology, 2011
- Development of radiotracers for oncology – the interface with pharmacologyBritish Journal of Pharmacology, 2011
- Phase I TrialsJournal of Psychiatric Practice, 2011
- The Economic Burden of Incidentally Detected FindingsRadiologic Clinics of North America, 2011
- Incidental findings found in “healthy” volunteers during imaging performed for research: current legal and ethical implicationsBritish Journal of Radiology, 2010
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel AgentsClinical Cancer Research, 2010
- Managing Incidental Findings in Human Subjects Research: Analysis and RecommendationsJournal of Law, Medicine & Ethics, 2008
- Incidental Findings on Brain MRI in the General PopulationNew England Journal of Medicine, 2007
- Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapyThe American Journal of Cardiology, 2004